ArticleFrontiers in oncology2022

Heightened metabolic responses in NK cells from patients with neuroblastoma suggests increased potential for immunotherapy.

Karen Slattery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.